Atorvastatin: Difference between revisions

Jump to navigation Jump to search
Gerald Chi (talk | contribs)
Pratik Bahekar (talk | contribs)
No edit summary
Line 20: Line 20:


==Mechanism of Action==
==Mechanism of Action==
Inhibition of [[HMG-CoA reductase]]


==References==
==References==

Revision as of 14:54, 30 January 2014

Atorvastatin
Lipitor® FDA Package Insert
Indications and Usage
Dosage and Administration
Dosage Forms and Strengths
Contraindications
Warnings and Precautions
Adverse Reactions
Drug Interactions
Use in Specific Populations
Overdosage
Description
Clinical Pharmacology
Nonclinical Toxicology
Clinical Studies
How Supplied/Storage and Handling
Patient Counseling Information
Labels and Packages
Clinical Trials
ClinicalTrials.gov

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Pratik Bahekar, MBBS [2]

For patient information, click here.

Overview

Atorvastatin is a member of the drug class known as statins, used for lowering blood cholesterol. It also stabilizes plaque and prevents strokes through anti-inflammation and other mechanisms. Like all statins, atorvastatin works by inhibiting HMG-CoA reductase, an enzyme found in liver tissue that plays a key role in production of cholesterol in the body.

Category

US Brand Names

FDA Package Insert

Mechanism of Action

Inhibition of HMG-CoA reductase

References